MXPA99004821A - A baculovirus for the control of insect pests - Google Patents
A baculovirus for the control of insect pestsInfo
- Publication number
- MXPA99004821A MXPA99004821A MXPA/A/1999/004821A MX9904821A MXPA99004821A MX PA99004821 A MXPA99004821 A MX PA99004821A MX 9904821 A MX9904821 A MX 9904821A MX PA99004821 A MXPA99004821 A MX PA99004821A
- Authority
- MX
- Mexico
- Prior art keywords
- virus
- insects
- pxmnpv
- heliothis
- insect
- Prior art date
Links
- 241000238631 Hexapoda Species 0.000 title claims abstract description 54
- 241000607479 Yersinia pestis Species 0.000 title abstract description 30
- 241000701447 unidentified baculovirus Species 0.000 title abstract description 9
- 241000500437 Plutella xylostella Species 0.000 claims abstract description 23
- 241000700605 Viruses Species 0.000 claims description 54
- 241000256244 Heliothis virescens Species 0.000 claims description 10
- 241000256247 Spodoptera exigua Species 0.000 claims description 9
- 230000003612 virological Effects 0.000 claims description 9
- 241000255777 Lepidoptera Species 0.000 claims description 8
- 241000256251 Spodoptera frugiperda Species 0.000 claims description 8
- 241000255993 Trichoplusia ni Species 0.000 claims description 8
- 230000000749 insecticidal Effects 0.000 claims description 8
- 241001515776 Heliothis subflexa Species 0.000 claims description 7
- 241000209149 Zea Species 0.000 claims description 7
- 241000256257 Heliothis Species 0.000 claims description 5
- 150000001875 compounds Chemical class 0.000 claims description 3
- 210000004027 cells Anatomy 0.000 description 28
- 241000201370 Autographa californica nucleopolyhedrovirus Species 0.000 description 18
- 239000000126 substance Substances 0.000 description 13
- 238000000338 in vitro Methods 0.000 description 9
- 239000003795 chemical substances by application Substances 0.000 description 8
- 241000894007 species Species 0.000 description 8
- 241000255967 Helicoverpa zea Species 0.000 description 7
- 241001646398 Pseudomonas chlororaphis Species 0.000 description 7
- 201000009910 diseases by infectious agent Diseases 0.000 description 7
- 230000003472 neutralizing Effects 0.000 description 7
- 239000000575 pesticide Substances 0.000 description 7
- 230000032258 transport Effects 0.000 description 7
- 238000004113 cell culture Methods 0.000 description 6
- 238000004519 manufacturing process Methods 0.000 description 6
- 238000000034 method Methods 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 238000004166 bioassay Methods 0.000 description 5
- 239000012141 concentrate Substances 0.000 description 5
- 229920003013 deoxyribonucleic acid Polymers 0.000 description 5
- 238000010790 dilution Methods 0.000 description 5
- 230000002458 infectious Effects 0.000 description 5
- 239000002917 insecticide Substances 0.000 description 5
- 239000002245 particle Substances 0.000 description 5
- 238000007796 conventional method Methods 0.000 description 4
- 230000001418 larval Effects 0.000 description 4
- 238000006386 neutralization reaction Methods 0.000 description 4
- 241000233866 Fungi Species 0.000 description 3
- 210000002966 Serum Anatomy 0.000 description 3
- 230000005591 charge neutralization Effects 0.000 description 3
- 230000000120 cytopathologic Effects 0.000 description 3
- 201000010099 disease Diseases 0.000 description 3
- 230000001264 neutralization Effects 0.000 description 3
- 230000001717 pathogenic Effects 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- UCSJYZPVAKXKNQ-HZYVHMACSA-N 1-[(1S,2R,3R,4S,5R,6R)-3-carbamimidamido-6-{[(2R,3R,4R,5S)-3-{[(2S,3S,4S,5R,6S)-4,5-dihydroxy-6-(hydroxymethyl)-3-(methylamino)oxan-2-yl]oxy}-4-formyl-4-hydroxy-5-methyloxolan-2-yl]oxy}-2,4,5-trihydroxycyclohexyl]guanidine Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
- 210000001015 Abdomen Anatomy 0.000 description 2
- 241000566553 Anagrapha falcifera Species 0.000 description 2
- 241001367049 Autographa Species 0.000 description 2
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 241000255908 Manduca sexta Species 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241000255969 Pieris brassicae Species 0.000 description 2
- 206010035148 Plague Diseases 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 230000002411 adverse Effects 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 108090001123 antibodies Proteins 0.000 description 2
- 102000004965 antibodies Human genes 0.000 description 2
- 230000000443 biocontrol Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 235000005824 corn Nutrition 0.000 description 2
- 229910003460 diamond Inorganic materials 0.000 description 2
- 239000010432 diamond Substances 0.000 description 2
- 230000029087 digestion Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000000855 fungicidal Effects 0.000 description 2
- 239000000417 fungicide Substances 0.000 description 2
- 238000010353 genetic engineering Methods 0.000 description 2
- 239000001963 growth media Substances 0.000 description 2
- 238000011081 inoculation Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 244000052769 pathogens Species 0.000 description 2
- 238000007894 restriction fragment length polymorphism technique Methods 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 241000625764 Anticarsia gemmatalis Species 0.000 description 1
- 240000007087 Apium graveolens Species 0.000 description 1
- 235000015849 Apium graveolens Dulce Group Nutrition 0.000 description 1
- 235000010591 Appio Nutrition 0.000 description 1
- 241000238421 Arthropoda Species 0.000 description 1
- 241001203868 Autographa californica Species 0.000 description 1
- 241001367035 Autographa nigrisigna Species 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000701412 Baculoviridae Species 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N D-sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- KXGVEGMKQFWNSR-LLQZFEROSA-N Deoxycholic acid Chemical compound C([C@H]1CC2)[C@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@@H](CCC(O)=O)C)[C@@]2(C)[C@@H](O)C1 KXGVEGMKQFWNSR-LLQZFEROSA-N 0.000 description 1
- 206010018987 Haemorrhage Diseases 0.000 description 1
- 241000255990 Helicoverpa Species 0.000 description 1
- 241000701443 Helicoverpa zea single nucleopolyhedrovirus Species 0.000 description 1
- 108090000745 Immune Sera Proteins 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 210000004940 Nucleus Anatomy 0.000 description 1
- 229940049954 Penicillin Drugs 0.000 description 1
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
- 231100000674 Phytotoxicity Toxicity 0.000 description 1
- 241000500439 Plutella Species 0.000 description 1
- 241000282941 Rangifer tarandus Species 0.000 description 1
- 229960005322 Streptomycin Drugs 0.000 description 1
- CZMRCDWAGMRECN-GDQSFJPYSA-N Sucrose Natural products O([C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](CO)O1)[C@@]1(CO)[C@H](O)[C@@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-GDQSFJPYSA-N 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 230000001464 adherent Effects 0.000 description 1
- -1 adherents Substances 0.000 description 1
- 235000021405 artificial diet Nutrition 0.000 description 1
- 230000002238 attenuated Effects 0.000 description 1
- 239000005667 attractant Substances 0.000 description 1
- 229960000626 benzylpenicillin Drugs 0.000 description 1
- 239000003124 biologic agent Substances 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding Effects 0.000 description 1
- 231100000319 bleeding Toxicity 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 239000000969 carrier Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 230000031902 chemoattractant activity Effects 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 229960003964 deoxycholic acid Drugs 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000000378 dietary Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 210000002919 epithelial cells Anatomy 0.000 description 1
- 239000012091 fetal bovine serum Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000005755 formation reaction Methods 0.000 description 1
- 238000009396 hybridization Methods 0.000 description 1
- 239000002054 inoculum Substances 0.000 description 1
- 239000002418 insect attractant Substances 0.000 description 1
- 238000004920 integrated pest control Methods 0.000 description 1
- 230000007653 larval development Effects 0.000 description 1
- 231100000518 lethal Toxicity 0.000 description 1
- 230000001665 lethal Effects 0.000 description 1
- 230000000670 limiting Effects 0.000 description 1
- 230000002101 lytic Effects 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000002609 media Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000006011 modification reaction Methods 0.000 description 1
- 230000000361 pesticidal Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 230000000644 propagated Effects 0.000 description 1
- 230000002285 radioactive Effects 0.000 description 1
- 230000000717 retained Effects 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 238000009987 spinning Methods 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 238000003892 spreading Methods 0.000 description 1
- 239000003381 stabilizer Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000000346 sugar Nutrition 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 235000012222 talc Nutrition 0.000 description 1
- 210000001519 tissues Anatomy 0.000 description 1
- 241000701366 unidentified nuclear polyhedrosis viruses Species 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 239000010455 vermiculite Substances 0.000 description 1
- 229910052902 vermiculite Inorganic materials 0.000 description 1
- 235000019354 vermiculite Nutrition 0.000 description 1
- 230000017613 viral reproduction Effects 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Abstract
A novel Plutella xylostella baculovirus (PxMNPV) which is useful for the control of insect pests has been isolated. A variety of insect pests may be controlled by application of an insecticidally effective amount of the baculovirus to the locus or vicinity of the target insect.
Description
A BÁCULOVIRUS FOR THE CONTROL OF PESTS CAUSED BY INSECTS
Background? L IrtygntQ
Field of the Invention
The invention relates to a báculovirus for Plutella xylost? Lla, which can be used for the biological control of pests caused by insects.
Description of Known Technique
Chemical pesticides or fungicides are the most commonly used control agents against pests caused by insects in agriculture and forests, as well as in diseases caused by fungi. These agents are used annually in the United States, exceeding 350 billion pounds, to control pests and diseases in forest, agricultural and residential areas. Unfortunately, broad-spectrum insecticides and fungicides have adverse impacts not only on their target organisms but also on beneficial insects and fungi and, consequently, on the entire ecosystem. Insect-borne pests can also become resistant to these chemicals, so that new populations of pests can develop from insects that are resistant to these pesticides. Moreover, chemical residues present environmental risks and possible concerns regarding health.
The interest in biological agents to control insects and fungi is increasing as a consequence of the concern regarding the use of chemical pesticides. Biological control of pests caused by insects presents an alternative means to control pests that may play a role in integrated pest management and reduce the need for chemical pesticides. Generally, natural control agents have slight adverse ecological impact due to their specificity with respect to the target host. Long-term environmental risks and health concerns are not a factor with biological control agents because chemical residues are not present. However, biological control agents can suffer several disadvantages compared to chemical pesticides, including production cost, efficacy and stability.
Viruses that cause natural epizootic diseases within populations caused by insects are among the entomopathogens, which have developed as biological pesticides. A variety of viruses, including baculoviruses, are known to be valuable biological control agents for insects.
The báculoviruses are a huge group of viruses that are infectious only in arthropods (L.
K. Miller, Vector of Virus for Genetic Engineering in Invertebrates, in "Genetic Engineering in Plant Sciences", N. Panopoulous, Ed., Praeger Publ., No.., P.
203-224, 1981; Carstens, 1980, "Báculovirus - Friend of Man, Enemy of the
Insects? "Trends and Biochemical Science, 52: 107-110; Harrap and Payne," The
Structural Properties and the Identification of Viruses caused by Insects * in
Advances in Research on Virus, M.A., Lawfer, F.B. Bang, K. Maramorosh and K.M: Smith, Eds., Vol. 25, pgs. 273-355, Academic Press, N. Y., 1979).
In nature, infection is initiated when an insect ingests food contaminated with baculovirus particles, typically in the form of occlusion bodies (OB) that are composed of multiple viral particles embedded in a protein crystal containing the virus.
When consumed by susceptible insects, the protein crystal of the occlusion bodies dissolves in the alkaline environment of the insect's belly, releasing individual virus particles that invade the epithelial cells that cover the belly. Within the cell, the báculovirus migrates to the nucleus where reproduction takes place. Generally, two forms of báculovirus, occluded and extracellular virus (CVD) are produced during viral reproduction. Each of these viral particles, as well as the OB itself, have capsules or casings. Initially, extracellular viruses (ECV) are produced, acquiring an envelope as it leaves the cocoon of the cell surface. This extracellular virus (CVD) can then infect other cells within the insect, including fatty body cells, epidermal and hemolymphatic cells. After this initial stage of infection, the virus is produced, which occludes in occlusion bodies. The formation of occlusion bodies continues until the cell finally dies or is destroyed by lysine. Some báculoviruses infect all tissues in the host insect, so that at the end of the infectious process, the whole insect becomes liquid, releasing extremely large numbers of occlusion bodies that then become responsible for spreading the infection to others. insects See "The biology of the baculoviruses" by R. G. Granados and B. A. Federici, Eds., Vol. I and I !, CRC Press, Boca Raton, Fia., 1986.
Many báculoviruses infect insects that are pests of commercially important agricultural and forestry crops. Said báculoviruses are, therefore, potentially valuable as biological control agents. To date, a variety of different báculovirus have been registered for use as insecticides by the Environmental Protection Agency in E.U.A. One of these, the multiple polyhedral nuclear virus Autographa callfornlca (AcMNEV) is well recognized for its use as a biocontrol agent due to its wide range of Lepidoptera hosts. Another báculovirus, Anagrapha falcifera, multiple nuclear polyhedrosis virus (AfMNPV) was recently isolated from a celery worm and differs from AcMNPV in both its REN pattern and in its highest degree of infection for the larval subflexa Heliothis. The AfMNPV is approximately equally infectious for H. zea as for the larva of H. virescens and has a wide range that infects more than 30 species among 10 families of the order of the Lepidoptera.
Summary of the Invention
We have discovered a novel bilavirus Pluteila xylostella that is useful for the control of pests caused by insects. A variety of pests caused by insects can be controlled by applying an insecticidally effective amount of the báculovirus to the locus or to the proximity of the insect in question.
According to this discovery, the purpose of this invention is to provide a roundabout báculovirus that is useful as a biological control agent to control pests caused by insects.
It is also an object of this invention to provide a báculovirus that is effective for the control of a wide range of pests caused by insects, including Plutella xylostella, without the use of chemical insecticides.
Another object of the invention is to provide a method for controlling pests caused by insects by the use of báculoviruses as biological control agents.
Other objects and advantages of the present invention will become apparent from the following description.
Detailed Description of the Invention
The novel báculovirus for Plutella xylostella of this invention is a virus of multiple nuclear polyhedrosis that belongs to the family of Baculoviridae, and is hereby referred to as PxMNPV. This báculovirus was originally isolated from the larvae of the moth with diamond back, the Plutella xylostella, and the plaque were purified three times in Heliothis virescens cells. Microscopically, the virus isolated from the infected larvae was occluded in many multiple units in a protein crystal or body of occlusion (OB). In contrast to other known baculoviruses, PxMNPV is highly effective against P. xylostella. Moreover, PxMNPV is infectious not only for its homologous host, but also for a variety of other pests caused by insects.
The aforementioned PxMNPV of the present invention has been deposited under the Budapest Treaty in the American Type Culture Collection (12301 Parklawn Drive, Rockville, Maryland, 20852, USA) on September 27, 1996, and has been assigned the Deposit No. ATCC VR 2543.
For the purposes of this Invention, any isolation or clone of the d virus is effective. multiple nuclear polyhedrosis of Plutella xylostella (PxMNPV) that have the ATCC VR-2543 identifying features and that retain the ability to infect pests caused by insects, particularly P. xylostella.
Mass production of PxMNPV can be achieved using either conventional in vivo or in vitro techniques. In any of these cases, the virus that is collected is in the form of the occlusion bodies (OB) themselves that are produced in the host, as well as in cell cultures. In case of in vivo production, the virus typically spreads in larvae of susceptible species of insects, such as P. xylostella, Heliothis virescens, Helicoverpa zea, Trichoplusia ni, Spodoptera frugiperda, Heliothis subflexa and Spodoptera exigua. However, T. ni, H. Virescens and P. xylostella are preferred since these are the most susceptible hosts. Briefly, larvae of the host insect are raised on the basis of a conventional artificial diet and treated with a suspension of PxMNPV occlusion bodies. Infected larvae are collected, usually at death or before liquefaction, in about 2-5 days, homogenized and filtered to remove lumpy particles. The resulting homogenate can then be centrifuged to sediment a considerable waste, the float is discarded and the sediment is suspended in sterilized water or another vehicle and the spinning process is repeated.
An appropriate cell lytic agent, such as sodium deoxycholate can be added to the suspension during the process to remove any bacteria and contaminating cells. The final suspension already washed contains OB of PxMNVP, it can be retained and saved for later use. By way of example, the in vivo propagation processes that are suitable for use in the present instrument are described in detail by Hosteter and Puttler (U.S. Patent No. 4,911,913), the content of which is incorporated by reference herein. instrument.
Although the virus can be propagated in vivo, as described, such techniques are generally susceptible to contamination and entail intensive work. Therefore, in the preferred content, the virus is produced in cell culture. Mass production of the virus can be achieved in vitro using conventional techniques, such as described by Mclntosh (U.S. Patent No. 5,405,770, published April 11, 1995), or by Mclntosh and Ignoffo (1989, J. Invertebrate Pathology, 54: 97-102), the content of each of which is incorporated for reference in this instrument. According to this method, the cells of an appropriate insect cell line are integrated into a conventional culture medium and inoculated with the extracellular virus PxMNPV (ECV). Sources of inoculum or inocula include, for example, the infectious hemolymphatic (containing ECV) collected by bleeding from an infected insect, approximately two days after infection, or by the release of the OB virus by alkaline treatment. Of course, once a cell line has been infected, the ECV can be collected as described below and used to infect fresh cell cultures. A variety of insect cell lines are suitable for use in the present instrument, including but not limited to Heliothis subflexa (BCIRL-HS-AM1) (Mclntosh, US Patent No. 5,405,770), Plutella xylostella (BCIRL-PxEM1 ) (Kariuki, C, 1996, doctoral thesis); Spodoptera frugiperda (IPLB-SF21) (Vaughn et al., 1977, In Vitro, 13: 213-217); Trichoplusia ni (TN-CL1) (Mclntosh et al., 1974, In Vitro, 10: 1-5); Heliothis viriscens (BCIRL-HV-AM1) (Mclntosh et al., 1981, J. Invertebr. Pathol., 37: 258-264) and Heliothis zea (BCIRL-HZ-FB33) (Mclntosh et al., unpublished) . The highest yields of occlusion bodies have been obtained using the cell line of T. ni (TN CL1), and its use is, therefore, preferred. Other Lepidoptera cell lines suitable for use in the present instrument can be prepared using conventional techniques of the art. After inoculation, the cell culture is incubated for a sufficient time and under effective conditions that allow the virus to be produced.
During in vitro cell culture, both the occluded virus (OB) and the extracellular free virus (CVD) are produced, although the relative proportions may vary with the particular cell line that is used (ie, the TN-CL1 provides the higher proportion of OB). Both the ECV and the OB are effective as biocontrol agents, but the OBs may be more resistant to some environmental factors, such as desiccation. Viral agents (ECV and OB) can then be collected or harvested from the culture float using conventional techniques of the trade. The virus can be recovered, for example, by centrifugation and concentration of the float of the culture medium as described by Mclntosh and Ignoffo (1981, J. Invert, Pathology, 37: 258-264) or by Ignoffo and Mclntosh (1986, J. Invert, Pathology, 48: 289-295), the content of each of which is incorporated for reference in this instrument.
The virus can then be purified by conventional centrifugation of declining sucrose and plaque assay. The culture conditions including cell density, multiplicity of infection, time, temperature and means are not critical and can be easily determined by the practitioner skilled in the art.
As a practical matter, it is envisaged that the commercial formulas of the subject's viral pesticidal agent would be prepared directly from the cell culture, the larval homogenates or fractions derived from said homogenates, obviating the need to isolate the virus in its pure form. . Other suitable means could easily be determined by the artisan skilled in the art. Of course, for applications that demand a high degree of specificity, that is, a high level of predictability of the response that is intended by both organisms, the objective and the non-objective of this study, it would normally be preferred to prepare the pure or substantially pure virus formula. For example, it is possible that foreign substances in the larval material could have an undesirable effect with respect to the intended activity.
The potential of the PxMNPV dictates that it be applied jointly with a suitable transport or vehicle, agronomically acceptable, in the way that is used in the trade. Without limiting the foregoing, inert solids, such as talcum, vermiculite, cellulose or sugars, powders susceptible to moistening and inert liquids such as water or vegetable oils, are illustrative of the chemical carriers that are suitable. The virus can also be formulated in combination with conventional additives such as adherents, insect attractants (i.e., an insecticide that attracts insects, or an "attractant"), surface active substances, wetting agents, UV stabilizers, or other biological control agents or chemical insecticides to increase the insecticidal activity.
Depending on the substrate, the target species, the mode of application and the type of response desired, the concentration of the virus in the final compound can vary considerably, but typically should be at least between 5 x 1011 to 5 x 1012 occlusion bodies per acre. Factors such as phytotoxicity to the treated plant and tolerance of the non-target species can be used by the skilled artisan when determining the maximum level.
In the case of pathogenic insects such as viruses, it may be preferable to use biological transports to distribute the pathogen. A biological transport of this nature could be, for example, a species of insect that is closely related to the target species, but which, in itself, is relatively unaffected by the pathogen. In this disclosure, the word "transport" is defined to include both biological transport and inert chemical transport.
The level of the virus is administered in an amount effective to induce infection as predetermined by the routine examination. When the final response is plague mortality, an "effective amount" or "pesticidally effective amount" is defined as the way to denominate those amounts of virus that will result in a significant degree of mortality of a group examined compared to a group untreated The effective amount actually used may vary with the species of the pest, the stage of larval development, the nature of the substrate, the type of vehicle or transport, the period of! treatment and other related factors.
To be effective, the virus must be ingested by the insect; therefore, the virus must be applied directly to the target pests, or to the locus of the pest to be controlled or its environment. In the case of plants infested with the target pest, the virus will typically be applied to plant surfaces, such as foliage, either by spraying or sprinkling.
The viral pesticide included in this instrument is effective in controlling a variety of insects. Without wishing to limit ourselves to this, the pests of particular interest known as vulnerable to treatment are agronomically important insects, especially those of the order of the Lepidoptera, and specifically the moth with diamond back (Plutella xylostella), the tobacco worm (Heliothis virescens) , the corn worm (Helicoverpa zea), the cabbage worm (Tríchoplusia ni), the beetleworm (Spodoptera exigua), the Heliothis subflexa and the autumn worm (Spodoptem frugiperda).
The following examples are intended only to illustrate the invention in more detail and are not intended to limit the scope of the invention, which is defined by the claims.
Example 1
Endonuclear Restriction Analysis
PxMNPV DNA was compared with those of the following báculoviruses: Autographa califomica (AcMNPV), Anagrapha falcifera (AfMNPV), Heliothis zea (HzSNPV), Helicoverpa armígera (HaMNPV), and Anticarsia gemmatalis (AgMNPV). The DNA of each of these viruses was subjected to endonucleate restriction analysis using four different enzymes: Hindlll, Xhol, BstlIE, and BamHl. The digestion profiles of the enzymes were prepared and analyzed using conventional techniques such as those described in Mclntosh and Ignoffo (1986, Intervirology, 25: 172-176), the content of which was incorporated for reference in the present instrument. After the comparison, the digestion profiles showed that the PxMNPV DNA profiles differed from those of all the other viruses, especially in the restriction fragment length polymorphism (RFLP) generated by the above HINDIII and BamHT.
In addition to this, DNA hybridization studies of the baculoviruses were performed using a tube labeled as non-radioactive DNA of the PxMNPV, the results showed that the PxMNPV was distinctive, although related to the AcMNPV.
Example 2
Neutralization tests
PxMNPV was compared with AcMNPV and AfMNPV using an antibody neutralization assay. Several attenuated solutions (or dilutions) of AcMNPV rabbit antiserum shown in Table 1 were mixed with several dilutions of each virus and incubated for 2 hours at 28 ° C. The treated samples were then inoculated into cultures of susceptible cells, then incubated and examined during the 7 days after inoculation. The complete neutralization of the infectivity of an isolated virus by a high dilution of a known antiserum indicates that the isolation is identical to, or closely related to, the virus that was used to prepare the antiserum. The highest dilution of antisera resulting in zero CPE (production of OBs) is considered as the neutralizing concentrate.
The results are shown in Tables 1a, b and c. No cytopathic effect (CPE), that is, absence of production of OBs in the inoculated cells, indicates that the virus has been neutralized by the antibody. As shown in Table 1.a, in the 103TCID dose, the neutralizing concentrate of the AcMNPV is 1: 512, while the neutralizing concentrate of the PxMNPV is 1: 8 (Table 1b). On the other hand, the AfMNPV, which is a variant of the AcMNPV, has a neutralizing concentrate of 1: 256 (Table 1c), confirming its close relationship with the AcMNPV.
Example 3
Cultivation of Insect Cells
Six different cell lines of Lepidoptera were compared for their ability to grow and reproduce PxMNPV. The cell lines used were Heliothis subflexa (BCIRL-HS-AM1) (US Patent, Mclntosh, No. 5,405,770), Spodoptera frugiperda (IPLB-SF21) (Vaughn et al., 1977, In Vitro, 13: 213 -217), Trichoplusia ni (TN-CL1) (Mclntosh et al., 1974, In Vitro, 10: 1-5), Plutella xylostella BCIRL-PxEM1 (Kariuki, C, 1996, Doctoral thesis), Heliothis virescens (BCIRL-HV-AM1) (Mclntosh et al., 1981, In Vitro, 17: 649-650) and Heliothis zea (BCIRL-HZ-FB33) (Mclptosh et al., Unpublished). In Vitro studies were performed as described in the Mclntosh patent (US Patent No. 5,405,770) or in Mclntosh (1991, J. Invertebr.
Pathol., 57: 441-4421) the contents of each of which will be incised for reference in the present instrument.
A clone of PxMNPV was used to inoculate cultures of all cell lines. The inoculated cells were incubated at a temperature of 28 ° C for 7 days in a medium dβ TC199-MK containing 10% of fetal bovine serum and penicillin and streptomycin. Viral concentrates (TCIDso) were assayed using TN-CL1 cells as the indicator cell line and OBs were enumerated as previously described by Mclntosh et al., [1985, Interlogology 23: 150-156 and 1989, J. Invertebrate Pathology, idem] the content of each of which is unoffered for reference in this instrument.
All six cell lines were susceptible to PxMNPV, with TN-CL3 producing the highest number of OBs per cell.
Example 4
Biological assays
The PxMNPV was compared with two other báculoviruses, the AcMNPV and the AfMNPV, for its effectiveness against seven Lepidoptera pests using the normal biological assay as described in Ignoffo (1966, J. Invertebr. Pathol., 8: 531-536 ) and Ignoffo et al. (1974, Environmental Entomology, 3: 1 7-119), the content of each of which is unoffered for reference in this instrument. The effectiveness against the following pests was examined: the moth with diamond-shaped back (Plutella xylostella), the tobacco worm (Heliothis virescens), the corn worm (Helicoverpa zea), the cabbage worm (Trichoplusia ni), the beetleworm (Spodoptera exigua), the Heliothis subflexa and the autumn worm (Spodoptera frugiperda). Larvae of each species were placed twenty-four hours old on artificial dietary surfaces inoculated with various concentrations of OBs in a continuous feed assay. The mortality of the larvae was recorded on a daily basis, and was used to calculate the dose necessary to eliminate 50% of the insects (LCso) as well as the time necessary to achieve 50% mortality (LTso).
The results are shown in Tables 2a, b and c. As shown in the Table
2a, the PxMNPV was the most effective báculovirus against P. xylostella, requiring a LCM dose of only 5.54 OB per cm2. In contrast, LCso values for AcMNPV and AfMNPV against P. xylostella were 11,600 OB per cm (Table 2b) and 9.224 OB per cm 2 (Table 2c), respectively. With respect to the other pests caused by insects that were examined, the PxMNPV was also effective in comparison with the AcMNPV and the AfMNPV. In addition, the PxMNPV was the most effective against another important pest in the West and Southwest of the United States, the beetworm (S. exigua). The LCso values for the three baculoviruses against this pest were 69.61 OB per cm2 (PxMNPV), of 200.84 OB per cm2 (AcMNPV) and 167.59 OB per cm2 (AfMNPV) (Tables 2a, b and c).
The values of lethal time fifty (LTso) for PxMNPV, AcMNPV and AfMNPV against P. xylostella were 6 days, 100 days (extroplateados) and 132 days i (extroplateados), respectively, indicating that the PxMNPV eliminated the larva of the diamondback moth more quickly than the other báculovirus. A faster elimination results in less damage, caused by the plague caused by the insect, to the treated plants.
It is understood that the above detailed description is provided simply by way of illustration and that any modification or variation can be made therein provided the spirit and scope of the Invention is conserved.
Table 1: Neutralization reactions of the three different báculoviruses caused by Rabbit Antiserum of Autographa californica Multiple Nuclear Polyhedron Virus.
•
a) AcMNPV (wt) / Antiserum • - AcMNPV Anti-Concentration Virus Dilution (TCIDso l '\) serum 10s 104 103 10z 1 8 - - - 1 16 - - ~ 1 32 H ~ - 1 64 ++ ~ - 1 128 + + H ~ 1 256 ++ - + - 1 512 ++ ++ H 1 1024 ++ ++ - + 1 2048 ++ ++ ++ 1 4096 ++ ++ 1 8192 ++ ++ ++ C ontrol ++ ++ ++ + OB present - Absent OB [~ J Neutralizing concentration in various doses of virus
1 b) PxNPVCLI. Antiserum - AcMNPV Anti-Concentrated Virus Dilution (TCID50 / ml) serum 10s 104 103 10z 1 8 ++ - + H 1 16 ++ ++. + __ 1 32 ++ ++ _ + [..] 1 64 + + ++ - + - + 1 128 ++ ++ ++. + 1 256 ++ ++ ++ - + 1 512 ++ ++ - + 1 1024 ++ ++ ++ ++ 2048 + + ++ ++ ++ 1 4096 ++ ++ ++ 1 8192 ++ ++ ++ ++ C ontrol ++ ++ ++ + OB present - Absent OB [-] Neutralizing concentration in various dose of virus
O AfNMPVCLI / Antiserum - • AcMNPV Anti-Concentration Virus Dilution (TCIDso / ml) serum 10 * 104 103 10z 1 8 - - - 1. 16 H - - 1 32 + - H - 1. 64 ++ + - - 1 128 + + + - - 1 256 ++ + - H 1 512 ++ ++ + - 1 1024 ++ ++ + - 1 2048 ++ ++ + - 1 4096 ++ ++ + - 1: 8192 ++ ++ + - C ontrol ++ ++ + -
+ OB present - Absent OB [-] Neutralizing concentration in various doses of virus Table 2 Susceptibility of the various larval neonates from the lepidoptera to the báculoviruses a) PxMNPVCL3 Insect Curve + SE LCso (95% FL) a RRb
Plutella xylostella 0.60 + 0.03 5.54 (3.10-8.91) Helicovefa zea 0.88 + 0.03 36.79 (26.37-50.85) 6.64
Hellothis subflexa 1.38 + 0.05 24.06 (18.53-30.87) 4.34
Heliothis virescens 1.39 + 0.05 6.38 (4.96-8.12) 1.15
Trichoplusia ni 1.17 + 0.04 7.36 (5.49-9.67) 1.33
Spodoptera frugiperda 0.57 + 0.03 576.53 (331.27-1186.48) 104.07
Spodoptera exigua 2.09 + 0.09 69.61 (55.84-85.45) 12.56 a = OB / cmz (FL = Fiduciary Limits) b =; Proportion of resistance n = 150
b) AcMNPV (wt) Insect Curve + SE LCso (95% FL) * RRB Plutella xylostella 1.02 + a04 11600.22 (8534.89-4658.63 15776.59) Helicovefa zea 1.02 + 0.04"3.06 (2.07-4.27) 1.23
Heliothis subfíexa 1.18 + 0.04 22.12 (16.81-28.86) 8.88
Heliothis virescens 1.52 ± 0.06 4.73 (3.71-5.95) 1.89
Trichoplusia ni 1.31 + 0.06 2.49 (1.83-3.28) - Spodoptera frugiperda 1.04 + 0.05 606.72 (435.10-900.31) 243.66
Spodoptera exigua 1.59 + 0.06 200.84 (161.27-250.94) 80.66 a = OB / cm (FL = Fiduciary Limits) b = Proportion of resistance n = 150
Table 2 c) AfMNPVCLI Insect Curve + SE LCso (95% FL) 'RR "Plutella xylostella 0.82 + 0.03 9224.48 (6480.63-3859.6 13229.39) Helicovefa zea 0.86 + 0.03 76.23 (54.36-107.19) 31.89 Heliothis subflexa 1.86 + 0.08 4.29 (3.46 -5.28) 1.79 Heliothis vi scens 1.50 + 0.06 3.37 (2.61-4.27) 1.41 Trichoplusia ni 1.34 + 0.07 2.39 (1.77-3.10) Spodoptera frugiperda 1.00 + 0.04 186.31 (137.47-256.14) 77.95 Spodoptera exigua 1.47 + 0.06 167.59 (131.88-212.46) ) 70.12 a = ÓB / cmz (FL = Fiduciary Limits) b = Proportion of resistance n = 150
Claims (7)
1. A viral agent comprising a biologically pure multiple polyhedrosis virus of Plutella xylostella containing all the characteristics that identify ATCC VR-2543.
2. The viral agent of claim number 1 wherein said virus is occluded in an occlusion body.
3. An insecticidal compound comprising the virus of claim number 1 and an agronomically acceptable transport.
4. The insecticidal compound of claim 3, wherein said transport is inert.
5. A method for controlling insects comprising the application of an insecticidally effective amount of the viral agent of claim number 1 to the locus of said insects.
6. The method of claim number 5 in which these insects are of the order of Lepidoptera.
7. The method of claim 6 in which said insects are selected from the group consisting of Plutella xylostella, Helicovefa zea, Heliothis subflexa, Heliothis virescens, Trichoplusia ni, Spodoptera frugiperda and Spodoptera exigua. The method of claim number 6, in which said insects are selected from the group consisting of Plutella xylostella, Helicovefa zea, Heliothis vírescens and Spodoptera exigua.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US08756301 | 1996-11-25 |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA99004821A true MXPA99004821A (en) | 2000-07-01 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU692290B2 (en) | Insect viruses, sequences, insecticidal compositions and methods of use | |
Moore | The development and evaluation of Cryptophlebia leucotreta granulovirus (CrleGV) as a biological control agent for the management of false codling moth, Cryptophlebia leucotreta, on citrus | |
Hamblin et al. | Co-occlusion and persistence of a baculovirus mutant lacking the polyhedrin gene | |
Tweeten et al. | Applied and molecular aspects of insect granulosis viruses | |
US4911913A (en) | Multiple embedded nuclear polyhedrosis virus from celery looper with activity against lepidoptera | |
Rao et al. | Role of nucleopolyhedroviruses (NPVs) in the management of lepidopteran pests in Asia | |
Vail et al. | Development of the multi-nucleocapsid nucleopolyhedroviruses (MNPVs) infectious to loopers (Lepidoptera: Noctuidae: Plusiinae) as microbial control agents | |
Fuxa et al. | Response of nuclear polyhedrosis virus-resistant Spodoptera frugiperda larvae to other pathogens and to chemical insecticides | |
Lee et al. | Occurrence and characterization of a nucleopolyhedrovirus from Maruca vitrata (Lepidoptera, Pyralidae) isolated in Taiwan | |
US6042843A (en) | Baculovirus for the control of insect pests | |
Jones | Bioassays of entomopathogenic viruses. | |
Fuxa et al. | Virulence and multigeneration passage of a nuclear polyhedrosis virus selected for an increased rate of vertical transmission | |
De Marzo et al. | Possible dissemination zyxwvutsrqpo of Spilocaea oleagina conidia by insects (Ectopsocus briggsi)' | |
Hernández-Crespo et al. | Response of hosts of varying susceptibility to a recombinant baculovirus insecticide in the field | |
MXPA99004821A (en) | A baculovirus for the control of insect pests | |
US6156309A (en) | Insecticidal compositions and methods | |
Gencer et al. | An epizootic by a new nucleopolyhedrovirus variant on the Pale tussock larvae (Lepidoptera: Lymantriidae) in oriental beech forest | |
Mulock et al. | Field Studies of a Genetically Modified Baculovirus, Autographa californicaNuclear Polyhedrosis Virus | |
McIntosh | Baculovirus for the control of insect pests | |
CN1141648A (en) | Biological control agent comprising an isolated polyhedrosis virus | |
Williams et al. | Selection for a moderately insecticide resistant clone of Myzus persicae (Hemiptera: Aphididae) on sugarbeet in the absence of pesticides | |
Mora et al. | A reliable bioassay procedure to evaluate per os toxicity of Bacillus thuringiensis strains against the rice delphacid, Tagosodes orizicolus (Homoptera: Delphacidae) | |
Kariuki | A new baculovirus isolate for the control of the diamondback moth, Plutella xylostella (L.)(Plutellidae: Lepidoptera) | |
Ludewig | The establishment of a virus free laboratory colony of Cryptophlebia leucotreta (false codling moth) and characterisation of Cryptophlebia leucotreta granulovirus (CrleGV) genes | |
Grasela | In vitro and in vivo host range of the velvetbean caterpillar Anticarsia gemmatalis (Huebner) multiple nuclear polyhedrosis virus (AgMNPV) |